Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025)

Camp4 Therapeutics' Treasury Shares history spans 3 years, with the latest figure at $4277.0 for Q1 2025.

  • On a quarterly basis, Treasury Shares changed N/A to $4277.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $4277.0, a N/A change, with the full-year FY2024 number at $15943.0, down 78.53% from a year prior.
  • Treasury Shares hit $4277.0 in Q1 2025 for Camp4 Therapeutics, down from $15943.0 in the prior quarter.
  • Over the last five years, Treasury Shares for CAMP hit a ceiling of $74243.0 in Q4 2023 and a floor of $4277.0 in Q1 2025.
  • Historically, Treasury Shares has averaged $31267.5 across 3 years, with a median of $23275.0 in 2024.
  • The widest YoY moves for Treasury Shares: up 78.53% in 2024, down 78.53% in 2024.
  • Tracing CAMP's Treasury Shares over 3 years: stood at $74243.0 in 2023, then tumbled by 78.53% to $15943.0 in 2024, then plummeted by 73.17% to $4277.0 in 2025.
  • Business Quant data shows Treasury Shares for CAMP at $4277.0 in Q1 2025, $15943.0 in Q4 2024, and $30607.0 in Q3 2024.